Literature DB >> 1782479

Apparent polycythaemia.

T C Pearson1.   

Abstract

Patients with apparent polycythaemia are characterised by a raised packed cell volume (PCV; males above 0.51, females above 0.48) but normal red cell mass (RCM; less than 25% greater than predicted). Prediction and interpretation of RCM and PV should be based on height and weight, since the use of body weight alone is misleading. Patients with PCV values up to 0.60 may have apparent polycythaemia but only 18% have a reduced PV (relative polycythaemia). Therefore, the most common cause of the raised PCV is a change in RCM and/or PV within their normal ranges. The clinical associations and possible causes for the RCM/PV changes include male sex, obesity, dehydration, diuretics, smoking, hypertension, alcohol, arterial oxygen desaturation, renal disease and increased catecholamine levels. Retrospective studies of patients with apparent polycythaemia and information from other groups of polycythaemic patients suggest an increased risk of vascular occlusion, although other factors, such as hypertension and smoking, are also involved. Proposed management includes modification of possible underlying causes and examination for risk factors for vascular occlusion. In patients with PCV levels chronically above 0.54 venesection should be used, but patients with PCV values below this level should only be venesected if they are considered to be at risk of vascular occlusion. The suggested target value for PCV for venesected patients is 0.45 or below.

Entities:  

Mesh:

Year:  1991        PMID: 1782479     DOI: 10.1016/0268-960x(91)90010-a

Source DB:  PubMed          Journal:  Blood Rev        ISSN: 0268-960X            Impact factor:   8.250


  9 in total

Review 1.  Best practice in primary care pathology: review 3.

Authors:  W S A Smellie; J Forth; D Bareford; P Twomey; M J Galloway; E C M Logan; S R S Smart; T M Reynolds; C Waine
Journal:  J Clin Pathol       Date:  2006-08       Impact factor: 3.411

Review 2.  Current applications of therapeutic phlebotomy.

Authors:  Tarek Bou Assi; Elizabeth Baz
Journal:  Blood Transfus       Date:  2013-10-03       Impact factor: 3.443

3.  Diagnosis of polycythaemia.

Authors:  M Messinezy; T C Pearson
Journal:  J Clin Pathol       Date:  1998-01       Impact factor: 3.411

Review 4.  Rethinking the diagnostic criteria of polycythemia vera.

Authors:  T Barbui; J Thiele; A M Vannucchi; A Tefferi
Journal:  Leukemia       Date:  2013-12-19       Impact factor: 11.528

Review 5.  A refined diagnostic algorithm for polycythemia vera that incorporates mutation screening for JAK2(V617F).

Authors:  Ayalew Tefferi
Journal:  Curr Hematol Malig Rep       Date:  2006-06       Impact factor: 3.952

Review 6.  Investigation of patients with polycythaemia.

Authors:  T C Pearson; M Messinezy
Journal:  Postgrad Med J       Date:  1996-09       Impact factor: 2.401

7.  Back to the "Gold Standard": How Precise is Hematocrit Detection Today?

Authors:  Leonid Livshits; Tal Bilu; Sari Peretz; Anna Bogdanova; Max Gassmann; Harel Eitam; Ariel Koren; Carina Levin
Journal:  Mediterr J Hematol Infect Dis       Date:  2022-07-01       Impact factor: 3.122

Review 8.  JAK2 unmutated erythrocytosis: current diagnostic approach and therapeutic views.

Authors:  Naseema Gangat; Natasha Szuber; Animesh Pardanani; Ayalew Tefferi
Journal:  Leukemia       Date:  2021-05-21       Impact factor: 11.528

9.  Juvenile erythrocytosis in children after liver transplantation: prevalence, risk factors and outcome.

Authors:  Maddalena Casale; Domenico Roberti; Claudia Mandato; Raffaele Iorio; Maria Caropreso; Saverio Scianguetta; Stefania Picariello; Silverio Perrotta; Pietro Vajro
Journal:  Sci Rep       Date:  2020-06-16       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.